Home
Anavex Life Sciences AVXL paid Forbes-Tate $60K for lobbying in Q3 2025 · Health Issues
Trade details
- Type
- Lobbying report
- Amount
- $60,000
- Quarter
- Q3 2025
- Client
- Anavex Life Sciences
- Reported
- 25/10/19
Up 0.0% from last quarter
What else happened in Anavex Life Sciences around then
Filed or reported within 30 days of the trade day · 25/08/31~25/10/30Anavex Life Sciences's other lobbying reports
- Anavex Life Sciences
LobbyingAnavex Life Sciences
LobbyingAnavex Life Sciences
AVXL
$40K
$40K
Reported 04/17
for Q1
- Anavex Life Sciences
LobbyingAnavex Life Sciences
LobbyingAnavex Life Sciences
AVXL
$60K
$60K
Reported 01/18
for Q4 2025
- Anavex Life Sciences
LobbyingAnavex Life Sciences
LobbyingAnavex Life Sciences
AVXL
$60K
$60K
Reported 25/07/18
for Q2 2025
- Anavex Life Sciences
LobbyingAnavex Life Sciences
LobbyingAnavex Life Sciences
AVXL
$60K
$60K
Reported 25/04/18
for Q1 2025